Press release
A 'Silver Lining' for Ascending Thoracic Aortic Aneurysms
Thoracic Aortic Aneurysm Market
A thoracic aortic aneurysm (TAA) is a serious cardiovascular condition characterized by abnormal dilation of the aorta within the chest, which can lead to life-threatening complications if left untreated, including dissection and rupture. Risk factors include hypertension, atherosclerosis, connective tissue disorders, and genetic syndromes such as Marfan and Loeys-Dietz.
Although TAAs are relatively rare compared to abdominal aortic aneurysms, they carry high morbidity and mortality risks. Early detection through imaging and advancements in minimally invasive surgical techniques have improved survival rates. Over the next decade, the thoracic aortic aneurysm market is expected to expand, driven by rising cardiovascular disease prevalence, growing adoption of endovascular procedures, and advances in stent graft technology.
Download Full PDF Sample Copy of Market Report @
https://exactitudeconsultancy.com/request-sample/72670
Market Overview
• The global thoracic aortic aneurysm market size in 2024 is estimated at USD 2.4 billion.
• It is projected to reach USD 5.8 billion by 2034, growing at a CAGR of 9.1 % during the forecast period.
• Market growth is supported by increasing awareness, technological advancements, and rising demand for minimally invasive procedures.
Key Market Drivers:
• Increasing prevalence of hypertension and atherosclerosis worldwide.
• Advancements in imaging techniques (CT, MRI, echocardiography).
• Growing adoption of thoracic endovascular aortic repair (TEVAR).
• Expanding aging population at higher risk of aneurysms.
Key Challenges:
• High cost of advanced surgical and endovascular procedures.
• Limited access to specialized treatment centers in developing countries.
• Risk of complications such as endoleaks and stent graft migration.
Leading Players:
Medtronic plc, Cook Medical, W. L. Gore & Associates, Terumo Aortic, Endologix LLC, CryoLife, and Cardinal Health.
Segmentation Analysis
The thoracic aortic aneurysm market can be segmented as follows:
By Treatment Type
• Open Surgical Repair
• Endovascular Repair (TEVAR)
• Hybrid Procedures
By Product Type
• Stent Grafts
• Graft Prosthetics
• Others
By End-Use
• Hospitals
• Specialty Cardiac Centers
• Academic & Research Institutes
Summary:
Endovascular repair (TEVAR) is the fastest-growing treatment type, offering minimally invasive alternatives with reduced recovery times. Stent grafts dominate the product segment, driven by continuous technological innovations. Hospitals remain the primary treatment centers, while specialty cardiac centers are expanding due to focused expertise.
Explore Full Report here:
https://exactitudeconsultancy.com/reports/72670/thoracic-aortic-aneurysm-market
Regional Analysis
North America
• Largest market, contributing ~45 % of global revenues in 2024.
• Driven by advanced cardiovascular infrastructure, high disease awareness, and early adoption of TEVAR.
• Strong presence of leading device manufacturers like Medtronic and Gore.
Europe
• Germany, France, and the UK lead with robust cardiovascular programs.
• EMA approvals and government initiatives supporting early diagnosis enhance adoption.
Asia-Pacific (APAC)
• Expected to record the fastest CAGR (~10.7 %) from 2024-2034.
• Rising incidence of hypertension and lifestyle-related disorders in China, India, and Japan.
• Expanding hospital infrastructure and increasing adoption of minimally invasive procedures.
Middle East & Africa (MEA)
• Early adoption, but high unmet need due to limited cardiac centers.
• GCC countries investing in advanced cardiovascular surgery programs.
Latin America
• Brazil and Mexico drive regional demand, supported by public and private healthcare investments.
Regional Summary:
North America and Europe dominate today's revenues, but Asia-Pacific is the fastest-growing market, with growing awareness, government health initiatives, and investment in advanced cardiovascular care.
Market Dynamics
Growth Drivers
1. Rising cardiovascular disease burden worldwide.
2. Technological advancements in stent grafts and imaging modalities.
3. Increasing demand for minimally invasive TEVAR procedures.
4. Expansion of cardiovascular research and screening programs.
Key Challenges
• Procedural risks including graft migration, endoleaks, and reinterventions.
• High treatment costs, particularly in emerging economies.
• Limited trained specialists for complex TAA surgeries.
Latest Trends
• Development of next-generation branched and fenestrated stent grafts.
• Increasing use of AI in imaging diagnostics for early aneurysm detection.
• Growth of patient-specific graft customization using 3D printing.
• Expansion of hybrid surgical-endovascular procedures.
Get Your Exclusive Offer with up to 10% Discount :
https://exactitudeconsultancy.com/checkout/?currency=USD&type=single_user_license&report_id=72670
Competitor Analysis
Major Players:
• Medtronic plc - Leading in endovascular stent graft technology.
• Cook Medical - Strong portfolio in aortic repair devices.
• W. L. Gore & Associates - Innovative stent graft systems.
• Terumo Aortic - Hybrid and open surgical repair solutions.
• Endologix LLC - Advanced minimally invasive repair technologies.
• CryoLife - Cardiovascular grafts and surgical products.
• Cardinal Health - Distribution and support for cardiovascular devices.
Competitive Summary:
The market is moderately consolidated, with leading device manufacturers dominating global revenues. Innovation in stent graft design, hybrid solutions, and AI-driven imaging partnerships are shaping competition. Collaborations with hospitals and research institutes remain essential for clinical adoption and regulatory approval.
Conclusion
The thoracic aortic aneurysm market is projected to grow from USD 2.4 billion in 2024 to USD 5.8 billion by 2034, at a CAGR of 9.1 %.
This report is also available in the following languages : Japanese (胸部大動脈瘤市場), Korean (흉부 대동맥류 시장), Chinese (胸主动脉瘤市场), French (Marché des anévrismes de l'aorte thoracique), German (Markt für thorakale Aortenaneurysmen), and Italian (Mercato dell'aneurisma aortico toracico), etc.
Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @
https://exactitudeconsultancy.com/request-sample/72670
Our More Reports:
Long Acting Drugs Market
https://exactitudeconsultancy.com/reports/72608/long-acting-drugs-market
Smart Labels Market
https://exactitudeconsultancy.com/reports/72610/smart-labels-market
SARM1 Inhibitor Market
https://exactitudeconsultancy.com/reports/72612/sarm1-inhibitor-market
About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
https://bulletin.exactitudeconsultancy.com/
https://www.thehealthanalytics.com/
https://www.analytica.global/
https://www.marketintelligencedata.com/
https://www.marketinsightsreports.com/
https://exactitudeconsultancy.com/
Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release A 'Silver Lining' for Ascending Thoracic Aortic Aneurysms here
News-ID: 4202318 • Views: …
More Releases from Exactitude Consultancy
For the targeted treatment of localized prostate cancer, photodynamic therapy
Introduction
Photodynamic therapy (PDT) is an innovative, minimally invasive treatment that combines photosensitizing agents, oxygen, and light to selectively destroy abnormal or cancerous cells. Originally developed for dermatological conditions, PDT has rapidly expanded into oncology, ophthalmology, and infectious diseases, offering a targeted therapy with fewer side effects compared to chemotherapy and radiation.
The rising prevalence of cancer, non-melanoma skin disorders, and antimicrobial resistance has made PDT an increasingly attractive therapeutic option. Over…
From mechanism of action to prospective immunotherapeutic methods, TIGIT in canc …
Introduction
The field of immuno-oncology has revolutionized cancer treatment, with checkpoint inhibitors such as PD-1, PD-L1, and CTLA-4 therapies transforming outcomes for patients with advanced malignancies. However, many patients still fail to respond or develop resistance, underscoring the need for new immune checkpoint targets. T-cell immunoreceptor with Ig and ITIM domains (TIGIT) has emerged as one of the most promising next-generation targets, showing strong potential to enhance anti-tumor immunity when combined…
Epstein-Barr Is Riskier Than You May Imagine
Introduction
The Epstein-Barr virus (EBV), a member of the herpesvirus family, is one of the most common human viruses, infecting nearly 90-95 % of the global population at some point in their lives. EBV is the primary cause of infectious mononucleosis ("mono") and is linked to several serious conditions, including Hodgkin's lymphoma, Burkitt's lymphoma, nasopharyngeal carcinoma, and multiple sclerosis (MS).
Despite its widespread prevalence and serious long-term health associations, no approved vaccines…
Plexiform Neurofibroma Market to Reach USD 1.1 Billion by 2034, Growing at 10.7% …
Introduction
Plexiform neurofibroma (PN) is a rare, benign but potentially disfiguring and debilitating tumor associated with neurofibromatosis type 1 (NF1), a genetic disorder caused by mutations in the NF1 gene. While benign, these tumors can grow extensively along nerves, leading to pain, functional impairment, and, in some cases, malignant transformation into malignant peripheral nerve sheath tumors (MPNSTs).
Historically, treatment options were limited to surgery, often complicated by high recurrence rates and incomplete…
More Releases for Aortic
Intra Aortic Balloon Pumps Market
Intra-aortic balloon pumps (IABP) are medical devices used to support heart function in patients with severe coronary artery disease, heart failure, or other cardiovascular conditions. These devices work by inflating and deflating a balloon placed in the aorta, which helps improve blood flow to the heart and vital organs. IABPs are primarily used in critical care settings, including cardiac surgery, heart attack recovery, and as a bridge to more definitive…
Intra-Aortic Balloon Pump Market Clearly identifies the medical device focus. In …
InsightAce Analytic Pvt. Ltd. announced the addition of new market research report in its portfolio. 'Global Intra-aortic Balloon Pump Market Assessment - Revenue and Volume Forecast, Historic Revenue and Forecast Till 2028
Global Intra-aortic Balloon Pump market report is segmented based on product type, application and geography. Based upon product type Global Intra-aortic Balloon Pump Market is classified as Product iPulse,Corart BP3,Cardiosave, CS,Corart BP3, ULTRA 7FR,Sensation Catheter ,LINEAR Catheter ,MEGA Catheter
Get…
Endovascular Abdominal Aortic Aneurysm Repair Devices Market - Transforming Aort …
Newark, New Castle, USA: The "Endovascular Abdominal Aortic Aneurysm Repair Devices Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors.
Endovascular Abdominal Aortic Aneurysm Repair Devices Market: https://www.growthplusreports.com/report/endovascular-abdominal-aortic-aneurysm-repair-devices-market/8843
This…
Aortic Aneurysm Market - Transforming the Aortic Aneurysm Landscape: Redefining …
Newark, New Castle, USA: The "Aortic Aneurysm Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Aortic Aneurysm Market: https://www.growthplusreports.com/report/aortic-aneurysm-market/8565
This latest report researches the industry structure, sales,…
Rising Prevalence of Aortic Aneurysms Driving the Aortic Intervention Market
The global 𝐀𝐨𝐫𝐭𝐢𝐜 𝐈𝐧𝐭𝐞𝐫𝐯𝐞𝐧𝐭𝐢𝐨𝐧 market is estimated to attain a significant valuation by the end of 2031, states a study by Transparency Market Research (TMR). Besides, the report notes that the market is prognosticated to expand during the forecast period, 2021 - 2031.
The key objective of the TMR report is to offer a complete assessment of the global market including major leading stakeholders of the Aortic Intervention industry. The current…
Aortic Stents Grafts Market: Rising Prevalence of Aortic Aneurysm to Fuel the Gr …
The Aortic Stents Grafts Market research report provides an in depth examination of the key factors stimulating market expansion. It also sheds light on the challenges or restraining factors that are poised to hinder industry growth over the forecast timeframe. Growth rate, market share captured, and valuation estimates for each region, segment, and company are documented as well.
View Report - https://www.theinsightpartners.com/reports/aortic-stent-graft-market/
Aortic Stents Grafts is a new option for treatment of…
